Risk factors and clinical expression of HCV infection in hemodialysis patients

Nephron. 1992;61(3):313-4. doi: 10.1159/000186918.

Abstract

In our Dialytic Unit, the prevalence of antibodies to HCV (anti-HCV) was 16.4% in 1990 (73 hemodialyzed) and 21% in 1991 (105 hemodialyzed). The incidence of seroconversion was 13.1%. The transaminase behavior was similar in a group of anti-HCV-positive and a group of anti-HCV-negative patients and with previous HBV infection. Blood transfusions and dialytic age did not affect anti-HCV positivity.

MeSH terms

  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Hepacivirus / immunology
  • Hepatitis Antibodies / blood
  • Hepatitis C / etiology*
  • Hepatitis C / immunology
  • Hepatitis C / transmission
  • Humans
  • Middle Aged
  • Renal Dialysis / adverse effects*
  • Risk Factors
  • Transfusion Reaction

Substances

  • Hepatitis Antibodies
  • Aspartate Aminotransferases
  • Alanine Transaminase